Evidence map›Paper›PMID 25501848›Full record

ArticleOncology reports2015

Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formation.

Melannie Alexander, James B Burch, Susan E Steck, Chin-Fu Chen, Thomas G Hurley, Philip Cavicchia, Meredith Ray, Nitin Shivappa, Jaclyn Guess, Hongmei Zhang and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Journal of preventive medicine and hygiene · 2021
    Article
  9. Article
  10. Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.International journal of molecular sciences · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Melannie AlexanderSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
James B BurchSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Susan E SteckSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Chin-Fu ChenCenter for Molecular Studies, Greenwood Genetic Center, Greenwood, SC, USA.
Thomas G HurleySouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Philip CavicchiaSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Meredith RayDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Nitin ShivappaSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Jaclyn GuessSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Hongmei ZhangDivision of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA.
Shawn D YoungstedtCollege of Nursing and Health Innovation, and College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
Kim E CreekDepartment of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC, USA.
Stephen LloydSouth Carolina Medical Endoscopy Center, and Department of Family Medicine, University of South Carolina School of Medicine, Columbia, SC, USA.
Xiaoming YangMedical Chronobiology Laboratory, Dorn Department of Veterans Affairs Medical Center, Columbia, SC, USA.
James R HébertSouth Carolina Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
University of South Carolina · USArizona State University · USGreenwood Genetic Center · USMedical University of South Carolina · USUniversity of Memphis · US

Funding

TISSUE BIOREPOSITORYP20RR017698 · NCRR · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FAYAD, RAJA · 2002 to 2011
$22.5M
Training ProgramU54CA153461 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HEBERT, JAMES R · 2010 to 2015
$4.8M
Biomedical-Behavioral Interface: Prevention and Developmental Sciences TrainingT32GM081740 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI PRINZ, RONALD J · 2008 to 2022
$4.5M
South Carolina Cancer Disparities Community NetworksU01CA114601 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HEBERT, JAMES R · 2005 to 2010
$3.8M
Expanding Mentoring Capacity in High-Risk PopulationsK05CA136975 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HEBERT, JAMES R · 2009 to 2013
$801k
NCI NIH HHS 3 U01 CA114601-03S5NCI NIH HHS K05 CA136975NCI NIH HHS U01 CA114601NCI NIH HHS U54 CA153461NCIPC CDC HHS T32-5R18CE001240NCRR NIH HHS 5P20RR017698NCRR NIH HHS P20 RR017698NIGMS NIH HHS T32 GM081740
6 · The paper itself

Abstract

Clock genes are expressed in a self-perpetuating, circadian pattern in virtually every tissue including the human gastrointestinal tract. They coordinate cellular processes critical for tumor development, including cell proliferation, DNA damage response and apoptosis. Circadian rhythm disturbances have been associated with an increased risk for colon cancer and other cancers. This mechanism has not been elucidated, yet may involve dysregulation of the 'period' (PER) clock genes, which have tumor suppressor properties. A variable number tandem repeat (VNTR) in the PERIOD3 (PER3) gene has been associated with sleep disorders, differences in diurnal hormone secretion, and increased premenopausal breast cancer risk. Susceptibility related to PER3 has not been examined in conjunction with adenomatous polyps. This exploratory case-control study was the first to test the hypothesis that the 5-repeat PER3 VNTR sequence is associated with increased odds of adenoma formation. Information on demographics, medical history, occupation and lifestyle was collected prior to colonoscopy. Cases (n=49) were individuals with at least one histopathologically confirmed adenoma. Controls (n=97) included patients with normal findings or hyperplastic polyps not requiring enhanced surveillance. Unconditional multiple logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (CIs), after adjusting for potential confounding. Adenomas were detected in 34% of participants. Cases were more likely to possess the 5-repeat PER3 genotype relative to controls (4/5 OR, 2.1; 95% CI, 0.9-4.8; 5/5 OR, 5.1; 95% CI, 1.4-18.1; 4/5+5/5 OR, 2.5; 95% CI, 1.7-5.4). Examination of the Oncomine microarray database indicated lower PERIOD gene expression in adenomas relative to adjacent normal tissue. Results suggest a need for follow-up in a larger sample.

Indexed as

Polymorphism, GeneticAdenomaAdenomatous PolypsAdultAgedAged, 80 and overCase-Control StudiesColonoscopyColorectal NeoplasmsEndoscopyFemaleGenotypeHeterozygoteHomozygoteHumansMalePER3 protein, humanPeriod Circadian Proteins

Identifiers

PMID25501848
PMCPMC4306271
OpenAlexW2051924993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.